Format

Send to

Choose Destination
See comment in PubMed Commons below
Transfusion. 2012 May;52 Suppl 1:56S-64S. doi: 10.1111/j.1537-2995.2012.03624.x.

Use of point-of-care testing for plasma therapy.

Author information

  • 1Department of Pathology, Stanford University, and Transfusion Services, Stanford University Medical Center, Stanford, California 94305, USA. ltgoodno@stanford.edu

Erratum in

  • Transfusion. 2012 Nov;52(11):2496.

Abstract

Use of point-of-care testing (POCT) has been driven by limitations of laboratory-based testing as a tool for decisions for transfusions of blood components. Clinical settings such as liver transplantation, cardiothoracic surgery, and trauma are particularly in need of such diagnostic tests because of the complex coagulopathies that can develop in these settings of substantial hemorrhage and need for blood component support. Successful implementation of POCT requires collaboration between surgery, anesthesia, critical care, and the laboratory to ensure proper quality control of equipment, operator training and competency, medical records test results, billing procedures, and consensus-derived transfusion algorithms for cost-effective, targeted blood component transfusion support. In this review we summarize clinical evidence for the effectiveness of POCT, along with some future directions for this strategy.

© 2012 American Association of Blood Banks.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk